Any current/future new fundraising through debt or equity?

There is no mention of any planned new fundraising through debt or equity in the transcript. The company is currently focused on consciously downsizing its debt position, having repaid approximately INR 35 crores already in the first half of the year, with a target to possibly double that by year-end. The repayment of debt is being done predominantly through operating and working capital efficiencies. No new capex projects are planned for the upcoming year; only replacement capex is expected, indicating limited need for fresh funding. Overall, the company appears to prioritize reduced leverage

Any current/future capex/capital investment/strategic investment?

No major capex projects are planned for the upcoming year; focus will be on replacement capex only. (Page 6) Recently entered into a joint venture with Clean Max Enviro Private Limited by acquiring a 26% stake in Clean Max Anchorage Private Limited for a total investment up to INR 3.36 crores. (Page 4) Clean Max Anchorage Private Limited will develop captive solar and wind power facilities in Gujarat with solar capacity of 2.31 MWp and wind capacity of 3.30 MW. (Page 4) The joint venture's project has a short payback period, expected around two years. (Page 10-11) No plans currently to venture

Future growth expectations in sales/revenue/volumes?

Pharma segment revenue is expected to increase over the next few quarters, potentially raising its share from the current lower range (35-60%) closer to the higher end. Filtration and drying segment shows a healthy order book with expected execution over 2-3 quarters, indicating a pickup after recent slack. The heat transfer equipment segment demonstrated 17% revenue growth, contributing INR 25 crores, expected to continue positive momentum. The consolidated order book grew 27% sequentially to INR 602 crores, providing visibility for 5-8 months of revenue. New product introductions, es

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects sustained growth driven by a diversified portfolio and strategic focus, with improved operational efficiencies. EBITDA margins in key segments like glass-lined equipment (GLE) are expected to stabilize between 17%-20% long-term. Filtration and drying business aims for sustainable margins in the 16%-18% range. Profitability and cash flows are expected to improve due to lower interest costs following debt reduction efforts. Debt reduction target for FY'25 is around INR 70 crores, enhancing profitability by reducing interest outlay. New product launches and service-oriented in

Current/ Expected Orderbook/ Pending Orders?

As of September 2024, HLE Glascoat's consolidated order book stands at approximately INR 602 crores, reflecting a sequential growth of 27%. The international business order book provides visibility for the next eight months, while the domestic market's order book offers visibility for around five months. The filtration, drying, and equipment segments experienced recent order book slack but show renewed momentum, particularly driven by the pharmaceutical sector in southern India. Despite some volatility, the company is optimistic about a promising pipeline of opportunities across domestic

HLE GlascoatQ2 FY25Industrial Manufacturing

HLE Glascoat Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹404.35P/E: 71.3Market Cap: ₹2.8K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Pharma segment revenue is expected to increase over the next few quarters, potentially raising its share from the current lower range (35-60%) closer to the higher end.
Filtration and drying segment shows a healthy order book with expected execution over 2-3 quarters, indicating a pickup after recent slack.
The heat transfer equipment segment demonstrated 17% revenue growth, contributing INR 25 crores, expected to continue positive momentum.
The consolidated order book grew 27% sequentially to INR 602 crores, providing visibility for 5-8 months of revenue.
New product introductions, especially automations and retrofit packages, aim to enhance customer engagement and drive growth via service and optimization.
International markets like the US are being penetrated more aggressively, with expectations for faster inroads due to strong service and innovative products.
The company anticipates sustained or improving margins with operational efficiencies and cross-selling opportunities, notably following Kinam's expansion into new sectors like oil and gas.

Margin guidance

Category 3

The company expects sustained growth driven by a diversified portfolio and strategic focus, with improved operational efficiencies.
EBITDA margins in key segments like glass-lined equipment (GLE) are expected to stabilize between 17%-20% long-term.
Filtration and drying business aims for sustainable margins in the 16%-18% range.
Profitability and cash flows are expected to improve due to lower interest costs following debt reduction efforts.
Debt reduction target for FY'25 is around INR 70 crores, enhancing profitability by reducing interest outlay.
New product launches and service-oriented innovations (like automation and retrofit packages) will enhance customer engagement and drive revenue growth.
The US market expansion, along with pharma sector traction, is expected to boost order book and revenues.
Improved working capital and operating cash flows will support steady earnings growth.
Overall PAT growth of 33% YoY was noted in Q2 FY'25, reflecting positive momentum into future quarters.

See what HLE Glascoat management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any planned new fundraising through debt or equity in the transcript.
The company is currently focused on consciously downsizing its debt position, having repaid approximately INR 35 crores already in the first half of the year, with a target to possibly double that by year-end.
The repayment of debt is being done predominantly through operating and working capital efficiencies.
No new capex projects are planned for the upcoming year; only replacement capex is expected, indicating limited need for fresh funding.
Overall, the company appears to prioritize reduced leverage and better cash flows rather than pursuing new fundraising at this time.

Order book

Yes

As of September 2024, HLE Glascoat's consolidated order book stands at approximately INR 602 crores, reflecting a sequential growth of 27%.
The international business order book provides visibility for the next eight months, while the domestic market's order book offers visibility for around five months.
The filtration, drying, and equipment segments experienced recent order book slack but show renewed momentum, particularly driven by the pharmaceutical sector in southern India.
Despite some volatility, the company is optimistic about a promising pipeline of opportunities across domestic and international markets in the coming quarters.

See what HLE Glascoat management said on order book — free account, 30 seconds.

Capex plans

No major capex projects are planned for the upcoming year; focus will be on replacement capex only. (Page 6)
Recently entered into a joint venture with Clean Max Enviro Private Limited by acquiring a 26% stake in Clean Max Anchorage Private Limited for a total investment up to INR 3.36 crores. (Page 4)
Clean Max Anchorage Private Limited will develop captive solar and wind power facilities in Gujarat with solar capacity of 2.31 MWp and wind capacity of 3.30 MW. (Page 4)
The joint venture's project has a short payback period, expected around two years. (Page 10-11)
No plans currently to venture into the Chinese market or to set up manufacturing facilities there. (Page 7)

Track HLE Glascoat — get its next earnings analysis in your feed

Margin guidance

Category 3

The company expects sustained growth driven by a diversified portfolio and strategic focus, with improved operational efficiencies.
EBITDA margins in key segments like glass-lined equipment (GLE) are expected to stabilize between 17%-20% long-term.
Filtration and drying business aims for sustainable margins in the 16%-18% range.
Profitability and cash flows are expected to improve due to lower interest costs following debt reduction efforts.
Debt reduction target for FY'25 is around INR 70 crores, enhancing profitability by reducing interest outlay.
New product launches and service-oriented innovations (like automation and retrofit packages) will enhance customer engagement and drive revenue growth.
The US market expansion, along with pharma sector traction, is expected to boost order book and revenues.
Improved working capital and operating cash flows will support steady earnings growth.
Overall PAT growth of 33% YoY was noted in Q2 FY'25, reflecting positive momentum into future quarters.

Order book

Yes

As of September 2024, HLE Glascoat's consolidated order book stands at approximately INR 602 crores, reflecting a sequential growth of 27%.
The international business order book provides visibility for the next eight months, while the domestic market's order book offers visibility for around five months.
The filtration, drying, and equipment segments experienced recent order book slack but show renewed momentum, particularly driven by the pharmaceutical sector in southern India.
Despite some volatility, the company is optimistic about a promising pipeline of opportunities across domestic and international markets in the coming quarters.

How does HLE Glascoat rank vs peers in Industrial Manufacturing?

Pro feature

ThisHLE Glascoat

Rev 3Mar 3

See where HLE Glascoat sits in Industrial ManufacturingSee which companies these are, and every other name in the sector.Open rankings

How does HLE Glascoat rank in Industrial Manufacturing?

Compare HLE Glascoat against every Industrial Manufacturing company (Q2 FY25) on revenue, margins and earnings-call signals.

View Industrial Manufacturing leaderboard →

What HLE Glascoat's management said in earlier quarters

Others in Industrial Manufacturing this season

The Anup Enginee (Q1 FY27)
New order book at best-ever levels (INR 985 crores), indicating robust future demand. Key concall takeaways from The Anup Engineering Ltd's Q1 FY27 earnings…
Hirect (Q1 FY27)
Long-term ambition to become a ₹1 billion revenue company within 4-5 years supported by expansion into propulsion systems, trainsets, and international…
MV Electrosystems (Q1 FY27)
Plan to reach a run rate of 40 propulsion systems per month, translating roughly to ₹700+ crores annual revenue in subsequent years. Key concall takeaways from…
Lohia Corp (Q1 FY27)
Capacity utilization is currently around 70-75%, with room to increase to 85% without major capex (Pages 16-17). Key concall takeaways from Lohia Corp Ltd's Q1…

Compare:vs Mazagon Dock Shipbuilders Ltd vs Aditya Infotech vs Cochin Shipyard Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

HLE Glascoat Q2 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

Margin guidance

Order book

How does HLE Glascoat rank in Industrial Manufacturing?

Continue your research

What HLE Glascoat's management said in earlier quarters

Others in Industrial Manufacturing this season